Diagnostic and prognostic applications of machine learning in paediatric traumatic brain injury: a systematic review of single and multimodal approaches

• by Zolisa Nkabinde, Abdullah Laher, Devon Jarvis

• July 14, 2026

FDA approves first therapy for warm autoimmune hemolytic anemia

The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.

• by Kathryn Wighton

• August 25, 2026

• 3 min

Nebulized epinephrine for croup in children: an updated systematic review

• by Yonggang Wei, Lei Li, Nian Wei, Yuanlin Pu, Jihua Zhao, Ping Xiong

• August 26, 2026

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

• by Kathryn Wighton

• August 28, 2026

• 2 min